Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleCLINICAL INVESTIGATIONS

Evidence for Pre- to Postsynaptic Mismatch of the Cardiac Sympathetic Nervous System in Ischemic Congestive Heart Failure

James H. Caldwell, Jeanne M. Link, Wayne C. Levy, Jeanne E. Poole and John R. Stratton
Journal of Nuclear Medicine February 2008, 49 (2) 234-241; DOI: https://doi.org/10.2967/jnumed.107.044339
James H. Caldwell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeanne M. Link
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wayne C. Levy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeanne E. Poole
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John R. Stratton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1. 

    Time line for radiotracer injection (arrows) and PET image acquisition. Attn = transmission image acquisition; CGP1 = high-specific-activity 11C-CGP; CGP2 = low-specific-activity 11C-CGP; H2O = 15O-water.

  • FIGURE 2. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2. 

    Decay-corrected 11C-mHED time–activity curves from myocardial and metabolite left atrial cavity (LA Cav) ROIs in CHF patient with our model fit to myocardial time–activity curves. (Left) Location of ROI 8 (arrowhead), a visually “normal” region, and the corresponding myocardial time–activity curve. (Right) Location of ROI 3, an abnormal mHED accumulation, is shown. ROIs are bounded by inside and outside arcs within each of 8 radial lines. Parameter estimates are given for PSnt, PSves (11C-mHED release by vesicles), V′nt (virtual volume of nerve terminal), and Gseq (rate vesicular storage of mHED). MBF and the retention fraction (RF) of 11C-mHED for the 2 ROIs are also shown.

  • FIGURE 3. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3. 

    Box-and-whisker plots for global values for MBF (left) and B′max (right) for healthy subjects (normal) and CHF patients. Box represents 25%–75% of data; whiskers represent 5%–95%; heavy and thin solid lines are mean and median values, respectively.

  • FIGURE 4. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4. 

    Short-axis PET images of 11C-mHED (35- to 45-min sum) and 11C-CGP (10- to 20-min sum from injection 1) in CHF patient. Apical slices are at upper left and basal slices are at lower right of each panel. Arrows indicate extensive mismatch between 11C-mHED and 11C-CGP.

  • FIGURE 5. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5. 

    Box-and-whisker plots for regional NE transport (PSnt) for 12 LV regions per subject. Locations of apical, middle, and basal slices lie between the white vertical bars on the long-axis image at upper left. Locations of large sectors—anterior, lateral, inferior, septal—are shown on short-axis image. Normals = healthy subjects.

  • FIGURE 6. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6. 

    Box-and-whisker plots of mismatch score, which is the postsynaptic-to-presynaptic ratio (B′max:PSnt) for the same 12 LV regions as in Figure 5. Normals = healthy subjects.

  • FIGURE 7. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 7. 

    B′max:PSnt from the 12 ROIs per individual subject are displayed as box-and-whisker plots (mean = heavy solid line). The 5%–95% whiskers indicate within-subject B′max:PSnt heterogeneity. Horizontal dotted line indicates 2 SD above the mean B′max:PSnt of healthy subjects (normals). Patients with an adverse outcome at 1.5 y of follow-up are indicated by the symbols shown.

Tables

  • Figures
    • View popup
    TABLE 1

    Clinical Characteristics of CHF Subjects

    Age (y)EFCADMINYHA classICDAmiodaroneβ-BlockerACEI or ARBEvent
    750.351vd3XXXX
    760.403vd3XXX
    750.45I3XXX
    670.123vd3XXSCD
    610.353vd2X
    670.21A4XXXTx
    730.34I2XX
    660.30I4XXXCHF
    770.35A2XXSCD
    670.23A4XX
    610.362vdA, L2XX
    760.402vd3XX
    680.293vdI2XXX
    • EF = ejection fraction; CAD = coronary artery stenosis of >50% diameter stenosis; MI = electrographic myocardial infarction (I = inferior, A = anterior, L = lateral); NYHA = New York Heart Association; ICD = implanted defibrillator; ACEI or ARB = angiotensin-converting enzyme inhibitor or angiotensin-receptor blocker; 1vd, 2vd, and 3vd = number of diseased vessels; SCD = new or recurrent ventricular fibrillation/ventricular tachycardia; Tx = transplanted; CHF = death from progressive CHF.

    • View popup
    TABLE 2

    Hemodynamics Before and After Radiotracer Injection

    11C-CGP1
    Radiotracer injectionHealthy subjectsCHF patients
    HR*SBP*DBP*HR*SBP*DBP*
    Before63.2 ± 8.0147 ± 1565.0 ± 10.774.7 ± 14†139 ± 3075.9 ± 11.3†
    After60.9 ± 8.9‡151 ± 13‡65.9 ± 8.869.2 ± 13.5†141 ± 2875.8 ± 13.2†
    11C-CGP2
    Before63.4 ± 8.7146 ± 1363.9 ± 9.572.0 ± 10.5†137 ± 2973.2 ± 11.4†
    After60.4 ± 8.3‡151 ± 12‡66.2 ± 9.3‡68.1 ± 9.2†140 ± 3071.6 ± 12.4
    11C-mHED
    Before62.2 ± 8.6148 ± 1265.0 ± 10.264.8 ± 8.7§135 ± 3368.2 ± 14§
    After61.3 ± 8.4152 ± 12‡66.2 ± 10.166.9 ± 8.6138 ± 34‡73.1 ± 15.5‡
    • CGP1 and CGP2 = first and second 11C-CGP injections; HR = heart rate; SBP = systolic blood pressure; DBP = diastolic blood pressure.

    • ↵* Mean ± SD.

    • ↵† P ≤ 0.05 vs. healthy subjects, unpaired t test.

    • ↵‡ P ≤ 0.05 before vs. after, paired t test.

    • ↵§ P ≤ 0.05 vs. CGP1, paired t test.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 49 (2)
Journal of Nuclear Medicine
Vol. 49, Issue 2
February 2008
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evidence for Pre- to Postsynaptic Mismatch of the Cardiac Sympathetic Nervous System in Ischemic Congestive Heart Failure
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Evidence for Pre- to Postsynaptic Mismatch of the Cardiac Sympathetic Nervous System in Ischemic Congestive Heart Failure
James H. Caldwell, Jeanne M. Link, Wayne C. Levy, Jeanne E. Poole, John R. Stratton
Journal of Nuclear Medicine Feb 2008, 49 (2) 234-241; DOI: 10.2967/jnumed.107.044339

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Evidence for Pre- to Postsynaptic Mismatch of the Cardiac Sympathetic Nervous System in Ischemic Congestive Heart Failure
James H. Caldwell, Jeanne M. Link, Wayne C. Levy, Jeanne E. Poole, John R. Stratton
Journal of Nuclear Medicine Feb 2008, 49 (2) 234-241; DOI: 10.2967/jnumed.107.044339
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Radiotracers to Address Unmet Clinical Needs in Cardiovascular Imaging, Part 1: Technical Considerations and Perfusion and Neuronal Imaging
  • Ventricular Tachycardia (VT) Substrate Characteristics: Insights from Multimodality Structural and Functional Imaging of the VT Substrate Using Cardiac MRI Scar, 123I-Metaiodobenzylguanidine SPECT Innervation, and Bipolar Voltage
  • 123I-MIBG Scintigraphy in the Subacute State of Takotsubo Cardiomyopathy
  • Global and Regional Myocardial Innervation Before and After Ablation of Drug-Refractory Ventricular Tachycardia Assessed with 123I-MIBG
  • Introduction to Cardiac Neuronal Imaging: A Clinical Perspective
  • Three-Dimensional 123I-Meta-Iodobenzylguanidine Cardiac Innervation Maps to Assess Substrate and Successful Ablation Sites for Ventricular Tachycardia: Feasibility Study for a Novel Paradigm of Innervation Imaging
  • Noninvasive Imaging in the Assessment of the Cardiopulmonary Vascular Unit
  • Altered Cardiac Innervation Predisposes to Ventricular Arrhythmia: Targeted Positron Emission Tomography Identifies Risk in Ischemic Cardiomyopathy
  • Acute Myocardial Infarction Inhibits the Neurogenic Tachycardic and Vasopressor Response in Rats via Presynaptic Cannabinoid Type 1 Receptor
  • Molecular Imaging of Thrombus: Technology in Evolution
  • Imaging Targets of the Sympathetic Nervous System of the Heart: Translational Considerations
  • Advances in SPECT and PET for the management of heart failure
  • Iodine-123 Metaiodobenzylguanidine Imaging and Carbon-11 Hydroxyephedrine Positron Emission Tomography Compared in Patients With Left Ventricular Dysfunction
  • Cardiac Autonomic Neuropathy in Diabetes: A clinical perspective
  • Cardiac Sympathetic Imaging With mIBG in Heart Failure
  • Will Imaging Assist in the Selection of Patients With Heart Failure for an ICD?
  • Imaging Left Ventricular Muscarinic Receptor Heterogeneity: A Tool to Evaluate Individuals at Risk for Sudden Death?
  • The Future of Cardiovascular Imaging in the Diagnosis and Management of Heart Failure, Part 1: Tasks and Tools
  • Google Scholar

More in this TOC Section

  • Feasibility of Ultra-Low-Activity 18F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System
  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
Show more Clinical Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire